Literature DB >> 19301653

Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo.

David L Gillespie1, Jeannette R Flynn, Brian T Ragel, Maria Arce-Larreta, David A Kelly, Sheryl R Tripp, Randy L Jensen.   

Abstract

Higher-grade gliomas are distinguished by increased vascular endothelial cell proliferation and peritumoral edema. These are thought to be instigated by vascular endothelial growth factor, which in turn is regulated by cellular oxygen tension. Hypoxia inducible factor-1alpha (HIF-1alpha) is a main responder to intracellular hypoxia and is overexpressed in many human cancers, including gliomas. Here we present methods for investigating the role of HIF-1alpha in glioma growth in vivo and in vitro using RNA interference in U251, U87, and U373 glioma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301653     DOI: 10.1007/978-1-60327-547-7_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Experimental validation of 5 in-silico predicted glioma biomarkers.

Authors:  Rheal A Towner; Randy L Jensen; Brian Vaillant; Howard Colman; Debra Saunders; Cory B Giles; Jonathan D Wren
Journal:  Neuro Oncol       Date:  2013-10-24       Impact factor: 12.300

2.  Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells.

Authors:  S H Shen; A L Kwan; Y Y Chen; Z X Wang
Journal:  Neurol Sci       Date:  2012-03-28       Impact factor: 3.307

3.  Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.

Authors:  Dueng-Yuan Hueng; Gu-Jiun Lin; Shing-Hwa Huang; Li-Wen Liu; Da-Tong Ju; Yuan-Wu Chen; Huey-Kang Sytwu; Chen Chang; Shih-Ming Huang; Yi-Shian Yeh; Horng-Mo Lee; Hsin-I Ma
Journal:  J Neurooncol       Date:  2010-11-30       Impact factor: 4.130

4.  ELTD1, a potential new biomarker for gliomas.

Authors:  Rheal A Towner; Randy L Jensen; Howard Colman; Brian Vaillant; Nataliya Smith; Rebba Casteel; Debra Saunders; David L Gillespie; Robert Silasi-Mansat; Florea Lupu; Cory B Giles; Jonathan D Wren
Journal:  Neurosurgery       Date:  2013-01       Impact factor: 4.654

5.  Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion.

Authors:  Xiuping Zhou; Zhi Liu; Qiong Shi; Jiantong Jiao; Wenbin Bian; Xu Song; Jianbing Mo; Ben Sang; Yinfu Xu; Jinming Qian; Yuewen Chao; Rutong Yu
Journal:  J Neurooncol       Date:  2013-03-09       Impact factor: 4.130

6.  The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.

Authors:  Shi-Yun Cui; Jia-Yuan Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Wei De; Rui Wang; Long-Bang Chen
Journal:  Cell Cycle       Date:  2013-08-07       Impact factor: 4.534

7.  Simulation predicts IGFBP2-HIF1α interaction drives glioblastoma growth.

Authors:  Ka Wai Lin; Angela Liao; Amina A Qutub
Journal:  PLoS Comput Biol       Date:  2015-04-17       Impact factor: 4.475

8.  Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.

Authors:  Elodie A Pérès; Aurélie N Gérault; Samuel Valable; Simon Roussel; Jérôme Toutain; Didier Divoux; Jean-Sébastien Guillamo; Marc Sanson; Myriam Bernaudin; Edwige Petit
Journal:  Oncotarget       Date:  2015-02-10

9.  Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery.

Authors:  Henry M Smilowitz; Alexandria Meyers; Khalil Rahman; Nathaniel A Dyment; Dan Sasso; Crystal Xue; Douglas L Oliver; Alexander Lichtler; Xiaomeng Deng; Sharif M Ridwan; Lauren J Tarmu; Qian Wu; Andrew L Salner; Ketan R Bulsara; Daniel N Slatkin; James F Hainfeld
Journal:  Int J Nanomedicine       Date:  2018-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.